To demonstrate the application of our fetal liver myeloid progenitor scheme, we analyzed the impact of deleting Runx1 (a mutation which causes a megakaryocytic differentiation block comparable to FPD/AML [38,46,48]) on the specification and differentiation of these compartments. This evidence concerns the gene RUNX1 and acute myeloid leukemia.